Detalhe da pesquisa
1.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
2.
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Blood
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557775
3.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
4.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
5.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300386
6.
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Blood
; 140(9): 1009-1019, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544601
7.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839452
8.
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Haematologica
; 109(4): 1163-1170, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794805
9.
Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.
Scand J Med Sci Sports
; 34(2): e14575, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339809
10.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
11.
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
Histopathology
; 82(7): 1105-1111, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849712
12.
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
Haematologica
; 108(3): 797-810, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226498
13.
Cellular therapy in lymphoma.
Hematol Oncol
; 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382086
14.
Conditional relative survival in Waldenström's macroglobulinaemia: a population-based study in The Netherlands.
Br J Haematol
; 196(5): 1205-1208, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738239
15.
Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population-based study in the Netherlands, 1989-2018.
Br J Haematol
; 196(3): 660-669, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605017
16.
IgM monoclonal gammopathies of clinical significance: diagnosis and management.
Haematologica
; 107(9): 2037-2050, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770530
17.
Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams.
Qual Life Res
; 31(8): 2357-2366, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298735
18.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
19.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590303
20.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 194(4): 690-700, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296427